Scott Boynton, DPM
Foot & Ankle Surgery · Portland, ORNPI 1487065777
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $107,328 of the $119,831 with a category attached, or 89.6%. Mimedx Group, Inc. accounts for 98.5% of it on its own, with 8 other manufacturers making up the rest. 2025 is the largest year on record at $81,902, more than ten times the $323 reported in 2022. Among foot & ankle surgery clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 99 payments — averaging $1210.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mimedx Group, Inc.$118K
- Smith+Nephew$677
- Integra Lifesciences Corporation$398
- Acera Surgical, Inc.$307
- Stryker$170
- Next Science LLC$150
- plus $84 from 3 others
What the payments were for
- Consulting fees$1,1001%
- Speaking & faculty fees$107,32890%
- Travel & lodging$7,9407%
- Food & beverage$3,1763%
- Other$2870%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mimedx Group, Inc. | 66 | $118,044 |
| Smith+Nephew | 22 | $677 |
| Integra Lifesciences Corporation | 2 | $398 |
| Acera Surgical, Inc. | 3 | $307 |
| Stryker | 1 | $170 |
| Next Science LLC | 2 | $150 |
| Treace Medical Concepts, Inc. | 1 | $36 |
| AbbVie | 1 | $25 |
| Solventum Corporation | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOVINE COLLAGEN$6,600
- ACell$287
- Restrata Wound Matrix$183
- CT THROMBECTOMY SYSTEM KIT$170
- FLOWTRIEVER CATHETER, S$170
- COLLAGENASE SANTYL$163
- ALLEVYN HEEL 10.5CM X 13.5CM CTN 5$163
- Stravix$163
- RENASYS TOUCH$163
- Grafix$163
- GRAFIX PL$146
- STRAVIX PL$146
- TCC-EZ$111
How this compares
$119,831 in reported general payments places this provider in the 95th percentile of 113 foot & ankle surgery providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 23 | $281 |
| Doxycycline Hyclate | 20 | $274 |
| Clotrimazole | 18 | $272 |
| Ciclopirox | 16 | $251 |
| Oxycodone Hcl | 12 | $62 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Portland
- Natalie MesnierPortland$339K
- Andrew ShinabargerPortland$85K
- Kevin DriscollPortland$21K
- John MassoudPortland$14K
- Kenneth HegewaldPortland$11K
- Steven LaxsonPortland$11K
- Lara AtwaterPortland$10K
- Denny lePortland$9K
- Andrew HuPortland$7K
- Paul JonesPortland$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.